SCHEMBL30496975

SCHEMBL30496975

NCc1cc(F)c2c(c1)CN(C1CCCNC1)C2=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 5/20 0.50
▸ HTR2B P41595 11/20 0.37
▸ HTR3E A5X5Y0 1/20 0.37
▸ HTR3B O95264 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ TMEM97 Q5BJF2 1/20 0.37
▸ HTR3D Q70Z44 1/20 0.37
▸ HTR3C Q8WXA8 1/20 0.37
▸ HTR2C P28335 10/20 0.37
▸ HTR2A P28223 7/20 0.37
▸ MAPK1 P28482 1/20 0.33
▸ POLB P06746 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ BMPR1A P36894 1/20 0.32
▸ ACVRL1 P37023 1/20 0.32
▸ ACVR1 Q04771 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30459676 0.89 PARP1 (0.50) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30351817 0.80 PARP1 (0.47) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL2333387 0.79 HTR2B (0.49) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30351699 0.79 PARP1 (0.47) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30496990 0.77 PARP1 (0.45) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30352272 0.76 PARP1 (0.44) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30352021 0.76 PARP1 (0.44) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30351630 0.75 PARP1 (0.46) PARP1HTR2BHTR3EHTR3BHTR3A
SCHEMBL30351393 0.75 PARP1 (0.45) PARP1
SCHEMBL25211492 0.73 CRBN (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457344-A Low molecular weight protein degradation agent and application thereof 凯普托尔治疗学股份有限公司 2023-07-18 — — CN disclosed
Send feedback